Difference in prevalence of exertional oscillatory ventilation between healthy subjects and patients with cardiovascular disease

Submitted: December 18, 2019
Accepted: March 1, 2020
Published: March 27, 2020
Abstract Views: 910
PDF: 554
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Exercise oscillatory ventilation (EOV) is an ominous sign in heart failure due to reduced left ventricular ejection fraction (HFrEF) whatever it is represented. But EOV is detected also in normal healthy individuals and in other cardiovascular disease (CVD) patients, however, its prevalence in these is not completed clear. The aim was to describe the occurrence of EOV in healthy subjects and the overall population all CVD patients who performing symptom limited cardiopulmonary exercise testing (CPET). Healthy subjects were divided in athletes and normal subjects, while, CVD patients were subdivided into: i) t hose with preserved left ventricular ejection fraction (LVEF); ii) those with mild to moderate impairment of LVEF (41-49%); iii) those with severe impairment of LVEF (≤40%); iv) HFrEF or with preserved LVEF (HFpEF); and iv) patients after heart transplantation (HXT). EOV was observed only in CVD patients and in those with depressed LVEF; the prevalence of EOV was observed 1.9% (3/55) those with mild to moderate impairment of LVEF (41-49%), 3.4% (56/1613) those with severe impairment of LVEF (≤40%), and 7.3% (214/2903) in HFrEF); no EOV was observed in CVD with preserved LVEF. Kremser’s EOV was observed in patients, and, particularly, in those with systolic function impairment. Moreover, as EOV impacts prognosis in HFrEF, its occurrence can modify prognostic-decision models. Even though, EOV prevalence was derived from largest single center population, more studies are needed to tackle the EOV prevalence in different CVD conditions and in normal subjects.



PlumX Metrics


Download data is not yet available.


Ugo Corrà, Division of Cardiology, ICS Maugeri, Institute of Veruno

Laboratory for the analysis of cardio-respiratory signals, ICS Maugeri, Institute of Veruno

How to Cite

Corrà, Ugo, Massimo Piepoli, and Andrea Giordano. 2020. “Difference in Prevalence of Exertional Oscillatory Ventilation Between Healthy Subjects and Patients With Cardiovascular Disease”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1203.